DE2223237C2 - Lösung zur pharmazeutischen Verwendung - Google Patents
Lösung zur pharmazeutischen VerwendungInfo
- Publication number
- DE2223237C2 DE2223237C2 DE2223237A DE2223237A DE2223237C2 DE 2223237 C2 DE2223237 C2 DE 2223237C2 DE 2223237 A DE2223237 A DE 2223237A DE 2223237 A DE2223237 A DE 2223237A DE 2223237 C2 DE2223237 C2 DE 2223237C2
- Authority
- DE
- Germany
- Prior art keywords
- solution
- sterile
- preservative
- sodium
- propan
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Otolaryngology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
Augentropfenlösung ohne Konservierungsmittel
Natriumchlorid (B.P.)
NaH1PO4 · 2H2O
Na2HPO4 ■ 12H2O
Dlnatriumedetat (B.P.) *)
Destilliertes Wasser
Nasenspraylösung mit Konservierungsmittel
vierungsmittel ersetzt werden:
Benzalkonlumchlorld (U.S.P.) | 0,01% |
Benzalkonlumchloridlösung (B.P.) | 0,02% |
Benzethonlumchiorld | 0,02% |
Cetrimld (B.P.) | 0,02% |
Myrlstyl-y-plkollnlumchlorid | 0,02% |
Chlorcresol (B.P.) | 0,1 % |
Chlorbutol (B.P.) | 0,5 % |
Chlorhexidln-Salze | 0,005-0,01% |
(z. B. Acetat, Glykonat) | |
Phenyl-quecksllber-II-Salze | 0,1 % |
(z. B. Nitrat, Acetat) | |
p-Hydroxybenzoat | 0,4-0,8 % |
Phtnyläthylalkohol (B.P.C. 1963) | 0,3-0,6 % |
Cetyipyridlniumchlorid (B.P.) | 0,02% |
Domlphenbromld (B.P.) | 0,01% |
oder Phenoxyäthanol (B.P.C.) | 0,5-1,0 % |
plus Phenyläthylalkohol
p-Hydroxybenzoate
plus Phenoxyäthanol (B.P.C.)
mit Konservierungsmittel
Dlnatriumedetat (B.P.)
Benzalkonlumchlorld-Lösung (B.P.)
Phenyläthylalkohol (BPC 1963)
Steriles destilliertes Wasser
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1452971 | 1971-05-12 | ||
GB5716971A GB1399834A (en) | 1971-05-12 | 1971-12-09 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2223237A1 DE2223237A1 (de) | 1972-12-14 |
DE2223237C2 true DE2223237C2 (de) | 1985-01-17 |
Family
ID=26250625
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19722266025 Pending DE2266025A1 (de) | 1971-05-12 | 1972-05-12 | |
DE2223237A Expired DE2223237C2 (de) | 1971-05-12 | 1972-05-12 | Lösung zur pharmazeutischen Verwendung |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19722266025 Pending DE2266025A1 (de) | 1971-05-12 | 1972-05-12 |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5425082B1 (de) |
AU (1) | AU465305B2 (de) |
BE (1) | BE782981A (de) |
CA (1) | CA1000201A (de) |
CY (1) | CY955A (de) |
DE (2) | DE2266025A1 (de) |
DK (1) | DK131324B (de) |
FR (1) | FR2139872B1 (de) |
GB (1) | GB1399834A (de) |
HK (1) | HK69276A (de) |
IE (1) | IE36337B1 (de) |
IL (1) | IL39286A (de) |
MY (1) | MY7700080A (de) |
NL (1) | NL177386B (de) |
SE (1) | SE396011B (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19614823A1 (de) * | 1996-04-15 | 1997-10-16 | Mann Gerhard Chem Pharm Fab | Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2230358A2 (en) * | 1973-05-25 | 1974-12-20 | Fisons Ltd | Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine |
DE2634908A1 (de) * | 1974-11-09 | 1977-04-14 | Fisons Ltd | Mittel zur behandlung chronischer haut- oder augenerkrankungen |
DE3700379A1 (de) * | 1987-01-08 | 1988-07-21 | Mann Gerhard Chem Pharm Fab | Konservierte augentropfen mit einem gehalt an cromoglicinsaeure |
AT410894B (de) * | 1988-03-22 | 2003-08-25 | Fisons Plc | Verwendung einer wässerigen lösung von natriumcromoglycat und chlorbutol |
GB8819490D0 (en) * | 1988-08-16 | 1988-09-21 | Fisons Plc | Pharmaceutical devices |
FR2649890A1 (fr) * | 1988-03-22 | 1991-01-25 | Fisons Plc | Compositions pharmaceutiques |
DE68915203T2 (de) * | 1988-03-22 | 1994-09-22 | Fisons Plc, Ipswich, Suffolk | Pharmazeutische Mischungen. |
WO1997024142A1 (fr) * | 1995-12-27 | 1997-07-10 | Showa Yakuhin Kako Co., Ltd. | Composition aqueuse contenant de l'acide cromoglycique |
EP0938896A1 (de) | 1998-01-15 | 1999-09-01 | Novartis AG | In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner |
JP5785353B2 (ja) * | 2004-02-27 | 2015-09-30 | 大正製薬株式会社 | 眼科用剤 |
JP5992293B2 (ja) * | 2012-10-31 | 2016-09-14 | 大正製薬株式会社 | 眼科用剤 |
PL426472A1 (pl) * | 2018-07-27 | 2020-02-10 | Kalbarczyk Grzegorz Arkona Laboratorium Farmakologii Stomatologicznej | Zastosowanie medyczne bromku domifenu oraz kompozycja do leczenia stanów zapalnych w obrębie jamy ustnej |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
GB1190193A (en) * | 1966-07-05 | 1970-04-29 | Fisons Pharmaceuticals Ltd | Bis-(2-Carboxy-Chromonyl-Oxy) Derivatives, their preparation, and Pharmaceutical Compositions thereof |
-
1971
- 1971-12-09 GB GB5716971A patent/GB1399834A/en not_active Expired
-
1972
- 1972-04-21 CY CY955A patent/CY955A/xx unknown
- 1972-04-24 IL IL39286A patent/IL39286A/xx unknown
- 1972-04-28 IE IE564/72A patent/IE36337B1/xx unknown
- 1972-05-01 CA CA140,981A patent/CA1000201A/en not_active Expired
- 1972-05-03 BE BE782981A patent/BE782981A/xx not_active IP Right Cessation
- 1972-05-09 AU AU42080/72A patent/AU465305B2/en not_active Expired
- 1972-05-09 NL NLAANVRAGE7206251,A patent/NL177386B/xx not_active Application Discontinuation
- 1972-05-09 SE SE7206151A patent/SE396011B/xx unknown
- 1972-05-10 DK DK232472AA patent/DK131324B/da not_active IP Right Cessation
- 1972-05-10 FR FR7216640A patent/FR2139872B1/fr not_active Expired
- 1972-05-12 JP JP4653772A patent/JPS5425082B1/ja active Pending
- 1972-05-12 DE DE19722266025 patent/DE2266025A1/de active Pending
- 1972-05-12 DE DE2223237A patent/DE2223237C2/de not_active Expired
-
1976
- 1976-11-04 HK HK692/76*UA patent/HK69276A/xx unknown
-
1977
- 1977-12-31 MY MY197780A patent/MY7700080A/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19614823A1 (de) * | 1996-04-15 | 1997-10-16 | Mann Gerhard Chem Pharm Fab | Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge |
Also Published As
Publication number | Publication date |
---|---|
DK131324B (da) | 1975-06-30 |
GB1399834A (en) | 1975-07-02 |
JPS5425082B1 (de) | 1979-08-25 |
HK69276A (en) | 1976-11-12 |
IE36337B1 (en) | 1976-10-13 |
DE2223237A1 (de) | 1972-12-14 |
NL177386B (nl) | 1985-04-16 |
IL39286A0 (en) | 1972-06-28 |
MY7700080A (en) | 1977-12-31 |
AU465305B2 (en) | 1975-09-25 |
FR2139872A1 (de) | 1973-01-12 |
AU4208072A (en) | 1973-11-15 |
NL7206251A (de) | 1972-11-14 |
IE36337L (en) | 1972-11-12 |
SE396011B (sv) | 1977-09-05 |
FR2139872B1 (de) | 1975-10-31 |
BE782981A (fr) | 1972-11-03 |
DE2266025A1 (de) | 1985-03-07 |
IL39286A (en) | 1975-02-10 |
DK131324C (de) | 1975-11-24 |
CA1000201A (en) | 1976-11-23 |
CY955A (en) | 1978-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2223237C2 (de) | Lösung zur pharmazeutischen Verwendung | |
DE69109021T2 (de) | Augentropfenarzneimittel. | |
CH645806A5 (de) | Augenheilmittel. | |
DE602005002495T2 (de) | Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat | |
DE69825625T2 (de) | Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen | |
AT409081B (de) | Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung | |
DE60103512T2 (de) | Pharmazeutische zusammensetzung enthaltend pemetrexed zusammen mit monothioglycerol, l-cystein oder thioglykolsäure | |
WO2001078732A1 (de) | Lagerstabile infusionslösung des ciprofloxacins | |
DE69021673T2 (de) | Stabile injizierbare pharmazeutische Formulation mit Folinsäure und Leukovorinsalze und Verfahren. | |
DE4139017A1 (de) | Waessrige piroxicam-loesungen und verfahren zu ihrer herstellung | |
DE69300017T2 (de) | Wässrige pharmazeutische Zubereitung von Natriumcromoglykat. | |
DE60132325T2 (de) | Ophthalmische lösung | |
DE2202964A1 (de) | Stabile,milde,nichttoxische,kampferhaltige Zubereitungen fuer die oertliche Behandlung mit entzuendungshemmender,antipruretischer und antibakterieller Wirkung | |
EP2040691B1 (de) | Wässrige arzneimittelformulierung von 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]- phenethyl}amino)methyl]benzoesäure | |
CH676549A5 (de) | ||
DE3700379C2 (de) | ||
EP1320368A1 (de) | Lagerstabile infusionslösung des ciprofloxacins mit verringertem säuregehalt | |
DE4233842A1 (de) | Mesna Injektionslösungen | |
DE3787274T2 (de) | Pharmazeutische Präparate, die eine wässerige Lösung eines Pyranoquinolins enthalten. | |
DE2422760A1 (de) | Stabilisierte catecholaminloesungen | |
EP0656777B1 (de) | Spritzfertige azosemid-injektionslösungen | |
DE2411019C2 (de) | Verwendung von 1-(4-(1-Pyrrolidinyl)-2-butynyl)-2-pyrrolidinon oder 1-(2-Oxo-1-pyrrolidin)-4-(1-pyrrolidin)-2-butyn zur Behandlung von Glaucoma | |
DE977478C (de) | Verfahren zur Herstellung injizierbarer Insulinpraeparate mit verzoegerter Wirkung | |
DE3720654C2 (de) | Pharmazeutische wäßrige Zusammensetzung und ihre Verwendung als Augen- oder Ohr-Präparat | |
AT215073B (de) | Verfahren zur Herstellung von Corticotropinpräparaten mit verlängerter Wirksamkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OD | Request for examination | ||
AG | Has addition no. |
Ref country code: DE Ref document number: 2425281 Format of ref document f/p: P |
|
D2 | Grant after examination | ||
8369 | Partition in: |
Ref document number: 2266025 Country of ref document: DE Format of ref document f/p: P |
|
Q171 | Divided out to: |
Ref country code: DE Ref document number: 2266025 |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: FISONS PLC, IPSWICH, SUFFOLK, GB |
|
8328 | Change in the person/name/address of the agent |
Free format text: WUESTHOFF, F., DR.-ING. FRHR. VON PECHMANN, E., DIPL.-CHEM. DR.RER.NAT. BEHRENS, D., DR.-ING. GOETZ, R., DIPL.-ING. DIPL.-WIRTSCH.-ING., PAT.-ANW., 8000 MUENCHEN |
|
8363 | Opposition against the patent | ||
8331 | Complete revocation |